COMPARATIVE BIOAVAILABILITY STUDY OF THEOPHYLLINE TABLETS MARKETED IN AUSTRALASIACHARLES BG; RAVENSCROFT PJ; BOCHNER F et al.1980; MED. J. AUST.; ISSN 0025-729X; AUS; DA. 1980; VOL. 2; NO 5; PP. 264-266; BIBL. 11 REF.Article

SEVERE HYPERKALAEMIA WITH MODURETICWHITING GFM; MCLARAN LJ; BOCHNER F et al.1979; MED. J. AUSTRAL.; AUS; DA. 1979; VOL. 1; NO 9; PP. 409; BIBL. 4 REF.Article

USE OF AN ERGOT PREPARATION (HYDERGINE) IN THE CONVALESCENT PHASE OF STROKE = UTILISATION D'UNE PREPARATION DE L'ERGOT (HYDERGINE) A LA PHASE DE CONVALESCENCE D'UNE HEMIPLEGIEBOCHNER F; EADIE MJ; TYRER JH et al.1973; J. AMER. GERIATR. SOC.; U.S.A.; DA. 1973; VOL. 21; NO 1; PP. 10-17; BIBL. 18REF.Serial Issue

Thromboembolism and its management in pregnancyJEFFRIES, W. S; BOCHNER, F.Medical journal of Australia. 1991, Vol 155, Num 4, pp 253-258, issn 0025-729XArticle

Determination of plasma aspirin and salicylic acid concentrations after low aspirin doses by high-performance liquid chromatography with post-column hydrolysis and fluorescence detectionSIEBERT, D. M; BOCHNER, F.Journal of chromatography. 1987, Vol 420, Num 2, pp 425-431, issn 0021-9673Article

SIMULTANEOUS LIQUID-CHROMATOGRAPHIC QUANTITATION OF SALICYCLIC ACID, SALICYLURIC ACID, AND GENTISIC ACID IN URINECHAM BE; BOCHNER F; IMHOFF DM et al.1980; CLIN. CHEM.; USA; DA. 1980; VOL. 26; NO 1; PP. 111-114; BIBL. 9 REF.Article

SIMULTANEOUS LIQUID-CHROMATOGRAPHIC QUANTITATION OF SALICYCLIC ACID, SALICYLURIC ACID, AND GENTISIC ACID IN PLASMACHAM BE; JOHNS D; BOCHNER F et al.1979; CLIN. CHEM.; USA; DA. 1979; VOL. 25; NO 8; PP. 1420-1425; BIBL. 24 REF.Article

SALICYLATE METABOLITE KINETICS AFTER SEVERAL SALICYLATESBOCHNER F; GRAHAM GG; CHAM BE et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 2; PP. 266-275; BIBL. 19 REF.Article

SINGLE-DOSE PHARMACOKINETICS OF METOCLOPRAMIDEROSS LEE LM; EADIE MJ; HOOPER WD et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 6; PP. 465-471; BIBL. 15 REF.Article

THE ELIMINATION OF PHENYTOIN IN MANEADIE MY; TYRER JH; BOCHNER F et al.1976; CLIN. EXPER. PHARMACOL. PHYSIOL.; G.B.; DA. 1976; VOL. 3; NO 3; PP. 217-224; BIBL. 18 REF.Article

DECREASED CAPACITY TO METABOLIZE DIPHENYLHYDANTOIN IN A PATIENT WITH HYPERSENSITIVITY TO WARFARINBOCHNER F; HOOPER WD; EADIE MJ et al.1975; AUSTRAL. NEW ZEAL. J. MED.; AUSTRAL.; DA. 1975; VOL. 5; NO 5; PP. 462-466; BIBL. 22 REF.Article

FACTORS INVOLVED IN AN OUTBREAK OF PHENYTOIN INTOXICATION = FACTEURS EN JEU DANS UNE EPIDEMIE D'INTOXICATION PAR LA PHENYTOINEBOCHNER F; HOOPER WD; TYRER JH et al.1972; J. NEUROL. SCI.; NETHERL.; DA. 1972; VOL. 16; NO 4; PP. 481-487; BIBL. 8REF.Serial Issue

Aspirin for myocardial infarction : clinical pharmacokinetic considerationsBOCHNER, F; LLOYD, J. V.Clinical pharmacokinetics. 1995, Vol 28, Num 6, pp 433-438, issn 0312-5963Article

The absorption and disposition of enoxacin in healthy subjectsSOMOGYI, A. A; BOCHNER, F.Journal of clinical pharmacology. 1988, Vol 28, Num 8, pp 707-713, issn 0091-2700Article

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?BOCHNER, F; LLOYD, J.Clinical science (1979). 1986, Vol 71, Num 6, pp 625-631, issn 0143-5221Article

MEASUREMENT AND PHARMACOKINETICS OF ACETYLSALICYLIC ACID BY A NOVEL HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAYCHAM BE; ROSS LEE L; BOCHNER F et al.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 4; PP. 365-372; BIBL. 16 REF.Article

DIPHENYLHYDANTOIN CONCENTRATIONS IN SALIVA = CONCENTRATIONS DE LA DIPHENYLHYDANTOINE DANS LA SALIVEBOCHNER F; HOOPER WD; SUTHERLAND JM et al.1974; ARCH. NEUROL.; U.S.A.; DA. 1974; VOL. 31; NO 1; PP. 57-59; BIBL. 16REF.Article

IN VIVO AND IN VITRO STUDIES ON THE BINDING OF SALICYLATE TO HUMAN PLASMA PROTEINS: EVIDENCE FOR ONE TYPE OF BINDING SITECHAM EB; BOCHNER F; IMHOFF DM et al.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 3; PP. 648-653; BIBL. 22 REF.Article

DOSE DEPENDENT PREDNISOLONE KINETICSTANNER A; BOCHNER F; CAFFIN J et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 5 PART. 1; PP. 571-578; BIBL. 15 REF.Article

Therapeutic drug monitoring and patient outcome : a review of the issuesTONKIN, A. L; BOCHNER, F.Clinical pharmacokinetics. 1994, Vol 27, Num 3, pp 169-174, issn 0312-5963Article

The clinician and therapeutic drug monitoring in the 1990sBOCHNER, F; TONKIN, A.Medical journal of Australia. 1993, Vol 158, Num 6, pp 422-426, issn 0025-729XArticle

PREDNISOLONE PHARMACOKINETICS IN ASTHMATIC PATIENTSMAY CS; CAFFIN JA; HALLIDAY JW et al.1980; BRIT. J. DIS. CHEST; GBR; DA. 1980; VOL. 74; NO 1; PP. 91-92; BIBL. 5 REF.Article

GLUTETHIMIDE AND 4-OH GLUTETHIMIDE: PHARMACOKINETICS AND EFFECT ON PERFORMANCE IN MAN.CROW JW; LAIN P; BOCHNER F et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 22; NO 4; PP. 458-464; BIBL. 19 REF.Article

EFFECT OF DOSAGE INCREMENT ON BLOOD PHENYTOIN CONCENTRATIONSBOCHNER F; HOOPER WD; TYRER JH et al.1972; J. NEUROL. NEUROSURG. PSYCHIATRY; G.B.; DA. 1972; VOL. 35; NO 6; PP. 873-876; BIBL. 8REF.Serial Issue

Page / 5